Concepedia

Hugh Wiltshire

HW

Statistics

Publications

27

Citations

2.1K

H-Index

19

Active since

1972

Affiliations

Roche (United Kingdom)(Current)

Roche (Switzerland)

The Netherlands Cancer Institute

Slotervaartziekenhuis

King's College London

Hugh Wiltshire is an author at Roche (United Kingdom) specializing in pharmacology, pharmacokinetics, and pharmacy.

Publications per year

1972–2012

27

Publications

27

Absence or pharmacological blocking of placental P-glycoprotein profoundly increases fetal drug exposure

Johan W. Smit, Maarten T. Huisman, Olaf van Tellingen et al. · Journal of Clinical Investigation · 1999 · 355 citations · Full text

, , +17

Multidrug resistance protein 2 (MRP2) transports HIV protease inhibitors, and transport can be enhanced by other drugs

Maarten T. Huisman, Johan W. Smit, Kristel M. L. Crommentuyn et al. · AIDS · 2002 · 223 citations

, , +17

A Placebo- and Midazolam-Controlled Phase I Single Ascending-Dose Study Evaluating the Safety, Pharmacokinetics, and Pharmacodynamics of Remimazolam (CNS 7056)

Hugh Wiltshire, Gavin J. Kilpatrick, Gary S Tilbrook et al. · Anesthesia & Analgesia · 2012 · 213 citations

, , +17

Pharmacodynamics of Oral Ganciclovir and Valganciclovir in Solid Organ Transplant Recipients

Hugh Wiltshire, Carlos V. Payá, Mark D. Pescovitz et al. · Transplantation · 2005 · 201 citations

, , +17

P-Glycoprotein Limits Oral Availability, Brain, and Fetal Penetration of Saquinavir Even with High Doses of Ritonavir

Maarten T. Huisman, Johan W. Smit, Hugh Wiltshire et al. · Molecular Pharmacology · 2001 · 166 citations

, , +17

1–5 of 27